Bringing COVID-19 vaccine to the world: A race of prowess - Part 3
This is known as Antibody Dependent Enhancement (ADE) of infection. Antibody Dependent Enhancement of infection must be ruled out in every vaccine against coronaviruses.
China says COVID-19 vaccine could be ready for public by November
A China-developed coronavirus vaccine could be ready for the public as early as November, a Chinese official has told state television, as the global race to clear the final round of trials heats up.
Bringing COVID-19 vaccine to the world; a race of prowess
In Professor Wole Soyinka’s play titled “The Lion and the Jewel”, the king or lion was able to win Sidi the village jewel as his wife. The village school teacher lost to the king. The king a much older man with multiple wives through his prowess won the heart of Sidi the village jewel. Lakunle,…
AstraZeneca pauses Covid-19 vaccine trial after unexplained illness
Pharmaceutical company AstraZeneca said Tuesday it had "voluntarily paused" a randomized clinical trial of its coronavirus vaccine in what it called a routine action...
Osinbajo wants equitable, affordable distribution of COVID-19 vaccine
Vice-President Yemi Osinbajo says the deployment of the COVID-19 vaccine should be done in an equitable and affordable manner rather than on the basis of the highest bidder.
US states told be ready to distribute COVID-19 vaccine by Nov 1
The Trump administration has urged US states to get ready to distribute a potential COVID -19 vaccine by November 1 -- two days before the presidential election.
Vaccine should be mandatory says Australia PM as race heats up
Australia's leader called Wednesday for coronavirus immunisations to be mandatory, wading into ethical and safety debates raging around the world as the race to develop a vaccine gathers pace.
Safety concerns as Russia approves ‘world’s first’ COVID-19 vaccine
Skepticism, yesterday, greeted the announcement by Russia that it had approved ‘‘world’s first’’ vaccine for COVID-19.
US signs $1 billion vaccine deal with Johnson & Johnson
The US government Wednesday announced a new $1 billion investment in a COVID-19 vaccine being developed by Johnson & Johnson, guaranteeing 100 million doses.